Literature DB >> 33435540

Imaging Characterization of Renal Masses.

Carlos Nicolau1, Natalie Antunes2, Blanca Paño1, Carmen Sebastia1.   

Abstract

The detection of a renal mass is a relatively frequent occurrence in the daily practice of any Radiology Department. The diagnostic approaches depend on whether the lesion is cystic or solid. Cystic lesions can be managed using the Bosniak classification, while management of solid lesions depends on whether the lesion is well-defined or infiltrative. The approach to well-defined lesions focuses mainly on the differentiation between renal cancer and benign tumors such as angiomyolipoma (AML) and oncocytoma. Differential diagnosis of infiltrative lesions is wider, including primary and secondary malignancies and inflammatory disease, and knowledge of the patient history is essential. Radiologists may establish a possible differential diagnosis based on the imaging features of the renal masses and the clinical history. The aim of this review is to present the contribution of the different imaging techniques and image guided biopsies in the diagnostic management of cystic and solid renal lesions.

Entities:  

Keywords:  computed tomography (CT); magnetic resonance imaging (MRI); renal cell carcinoma; renal cyst; renal mass; ultrasound

Mesh:

Substances:

Year:  2021        PMID: 33435540      PMCID: PMC7827903          DOI: 10.3390/medicina57010051

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  82 in total

Review 1.  Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review.

Authors:  Nicola Schieda; Matthew D F McInnes; Lilly Cao
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

Review 2.  CT and MR imaging for solid renal mass characterization.

Authors:  Kohei Sasaguri; Naoki Takahashi
Journal:  Eur J Radiol       Date:  2017-12-13       Impact factor: 3.528

3.  Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.

Authors:  Stephanie A Lee-Felker; Ely R Felker; Nelly Tan; Daniel J A Margolis; Jonathan R Young; James Sayre; Steven S Raman
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

4.  Differentiating between malignant and benign renal tumors: do IVIM and diffusion kurtosis imaging perform better than DWI?

Authors:  Yuqin Ding; Qinxuan Tan; Wei Mao; Chenchen Dai; Xiaoyi Hu; Jun Hou; Mengsu Zeng; Jianjun Zhou
Journal:  Eur Radiol       Date:  2019-06-03       Impact factor: 5.315

5.  Imaging features of primary renal lymphoma.

Authors:  Qingqiang Zhu; Wenrong Zhu; Jingtao Wu; Wenxin Chen
Journal:  Acta Radiol       Date:  2017-05-03       Impact factor: 1.990

6.  Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses.

Authors:  Chenchen Dai; Yingli Cao; Yan Jia; Yuqin Ding; Ruofan Sheng; Mengsu Zeng; Jianjun Zhou
Journal:  Abdom Radiol (NY)       Date:  2018-03

Review 7.  Birt-Hogg-Dubé syndrome: diagnosis and management.

Authors:  Fred H Menko; Maurice A M van Steensel; Sophie Giraud; Lennart Friis-Hansen; Stéphane Richard; Silvana Ungari; Magnus Nordenskjöld; Thomas Vo Hansen; John Solly; Eamonn R Maher
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

Review 8.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

9.  Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system.

Authors:  Gary M Israel; Nicole Hindman; Morton A Bosniak
Journal:  Radiology       Date:  2004-05       Impact factor: 11.105

10.  Is Ultrasound Useful for Further Evaluation of Homogeneously Hyperattenuating Renal Lesions Detected on CT?

Authors:  Mahadevaswamy Siddaiah; Satheesh Krishna; Matthew D F McInnes; Jeffrey S Quon; Wael M Shabana; Demetri Papadatos; Nicola Schieda
Journal:  AJR Am J Roentgenol       Date:  2017-07-05       Impact factor: 3.959

View more
  6 in total

1.  Imaging of the Kidney and Urinary Tract: Current and Future Trends.

Authors:  Maria Assunta Cova; Fulvio Stacul; Michele Bertolotto
Journal:  Medicina (Kaunas)       Date:  2022-05-19       Impact factor: 2.948

2.  Computed Tomography Image Features under Denoising Algorithm for Benign and Malignant Diagnosis of Renal Parenchymal Tumor.

Authors:  Zhongxiao Zhang; Zehua Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-05-27       Impact factor: 3.009

Review 3.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

4.  Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: A Study of Clinical, Imaging Features and Treatment Outcomes.

Authors:  Xiaofeng Xu; Jing Zhong; Xiumin Zhou; Zhifeng Wei; Qiuyuan Xia; Pengfei Huang; Changjie Shi; Jianping Da; Chaopeng Tang; Wen Cheng; Jingping Ge
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

5.  Cryptococcus granuloma mimicking local progressed tumor after cryoablation of renal cell carcinoma: A case report.

Authors:  Hikari Fukui; Masashi Fujimori; Takashi Yamanaka; Naritaka Matsushita; Seiya Kishi; Chisami Nagata; Yuki Omori; Kouhei Nishikawa; Hiroto Yuasa; Hajime Sakuma
Journal:  Radiol Case Rep       Date:  2022-07-22

6.  Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics.

Authors:  Khaled Bin Satter; Zach Ramsey; Paul M H Tran; Diane Hopkins; Gregory Bearden; Katherine P Richardson; Martha K Terris; Natasha M Savage; Sravan K Kavuri; Sharad Purohit
Journal:  Cancers (Basel)       Date:  2022-07-01       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.